KORU MEDICAL SYSTEMS Reports 6.0% Year-Over-Year Revenue Growth of USD 6.9 Million for Q2 Ending June 30, 2023

August 12, 2023

☀️Earnings Overview

KORU MEDICAL SYSTEMS ($NASDAQ:KRMD) declared a total revenue of USD 6.9 million for the second quarter ending June 30 2023, showing an increase of 6.0% from the same period in the prior year. Yet, their net income dropped to USD -2.5 million, a decline from the -2.9 million reported in the second quarter of 2022. The news was announced on August 9 2023.


Analyzing the financials of KORU MEDICAL SYSTEMS with GoodWhale can provide insights into its risk and performance. GoodWhale has detected 3 risk warnings in KORU MEDICAL SYSTEM’s income sheet, balance sheet, and cashflow statement. To get more detailed information, become a registered user and check out the full analysis of KORU MEDICAL SYSTEM’s financials. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis
  • About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for KRMD. More…

    Total Revenues Net Income Net Margin
    29.43 -8.11 -27.4%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for KRMD. More…

    Operations Investing Financing
    -5.59 -1.27 0.31
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for KRMD. More…

    Total Assets Total Liabilities Book Value Per Share
    36 7.89 0.61
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for KRMD are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    3.1% 37.4% -35.1%
    FCF Margin ROE ROA
    -23.3% -22.3% -17.9%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items

  • Peers

    Repro-Med Systems Inc. is a leading designer and manufacturer of specialty medical devices and pharmaceuticals. Its competitors are Merit Medical Systems Inc, Touchstone International Medical Science Co Ltd, and Medeon Biodesign Inc. All three companies are large, well-established firms with strong reputations in the medical device industry.

    – Merit Medical Systems Inc ($NASDAQ:MMSI)

    Medsite is a medical technology company that manufactures and markets medical devices and software. The company has a market capitalization of $3.33 billion and a return on equity of 5.86%. Medsite’s products are used by healthcare professionals worldwide to improve patient care and outcomes.

    – Touchstone International Medical Science Co Ltd ($SHSE:688013)

    The company’s market cap is 1.86B as of 2022 and its ROE is 3.8%. The company is engaged in the medical science field and is dedicated to providing innovative products and services to improve human health.

    – Medeon Biodesign Inc ($TPEX:6499)

    Medeon Biodesign Inc is a medical device company that designs, manufactures, and markets products for use in the fields of cardiology, orthopedics, and general surgery. The company has a market cap of 4.43B as of 2022 and a return on equity of -6.27%. Medeon Biodesign’s products are used in the treatment of conditions such as heart disease, arthritis, and cancer. The company’s products are sold through a network of distributors and retailers worldwide.


    KORU MEDICAL SYSTEMS reported total revenue of USD 6.9 million in the second quarter ending June 30 2023, indicating a 6.0% year-over-year growth. Net income decreased to USD -2.5 million, a decrease from the -2.9 million reported for the same quarter in the previous year. Investors must consider how these earnings results may impact the company’s future performance when making their decisions. The stock price should be monitored closely as market conditions continue to evolve to better understand how KORU MEDICAL SYSTEMS is affected.

    Recent Posts

    Leave a Comment